Pulmonary Hypertension (PH) Biorepository for Translational Research (NCT07647549) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Pulmonary Hypertension (PH) Biorepository for Translational Research
United States1,000 participantsStarted 2026-08-03
Plain-language summary
Background:
Pulmonary hypertension (PH) is high blood pressure in the blood vessels of the lungs. It can lead to heart failure and death if not treated. Researchers want to create a repository of blood samples and health information collected from people with PH. They hope to use this information to find better ways to diagnose and treat PH.
Objective:
To collect blood samples and health information from people suspected of or diagnosed with PH.
Eligibility:
People aged 18 years and older who have or may have PH.
Design:
Researchers will collect information from participants medical records.
Participants will have blood drawn from a vein. About 3 tablespoons will be collected during the study visit. The visit will last about 1 hour.
Participants may choose to provide new blood samples at follow-up visits. Updated medical information may also be collected.
Participants may continue to participate as long as the study is ongoing. Participants may opt out of providing new blood samples but remain in the study.
All study samples will be stored at the National Institutes of Health. Health information will be stored in secure databases.
Who can participate
Age range
18 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
* INCLUSION CRITERIA:
* Provision of signed and dated informed consent form
* Males and females aged \>=18 years old
* Suspected of or diagnosed with PH
* Able to understand and willing to sign a written informed consent document
EXCLUSION CRITERIA:
Any individual who does not meet all inclusion criteria or is deemed by the local investigator not to be a blood draw candidate will be excluded from participating in this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial is focused on building a biorepository — meaning it's mainly collecting biological samples and data rather than testing a new treatment — what would my actual participation involve, such as blood draws or tissue samples, and how often?
2This study isn't recruiting patients yet, so how long might it realistically be before I could even get involved, and is there a standard treatment I should be pursuing in the meantime?
3Because this is categorized as 'Phase NA,' it's not a traditional drug trial — so what benefit, if any, might I personally see from participating, versus this being primarily about helping future patients with pulmonary hypertension?
4Since this is a multi-center biorepository study, does it matter which participating center I enroll at, and could my involvement require travel or long-term follow-up visits that might be hard to manage?
5Are there other clinical trials for pulmonary hypertension that are actively recruiting right now and might offer me access to new treatments, which I could consider alongside or instead of this biorepository study?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Develop a multi-center biorepository.
Timeframe: 10 years
Trial details
NCT IDNCT07647549
SponsorNational Institutes of Health Clinical Center (CC)